Article By:
NASDAQ GlobeNewswire
Tuesday, June 6, 2017 11:28 AM EDT
Aeglea BioTherapeutics, Inc., today announced the pricing of its underwritten public offering of 3,000,000 shares of common stock at a public offering price of $4.10 per share, with expected gross proceeds to Aeglea of $12.3 million.
In this article: AGLE